|
US5506129A
|
|
Virus production
|
|
GB9108303D0
|
|
Asthma treatment
|
|
GB8909984D0
|
|
Separation method
|
|
GB8826882D0
|
|
Separation method
|
|
GB1479137A
|
|
Vacuum testing apparatus
|
|
GB1466286A
|
|
Coating of tablets
|
|
GB1397925A
|
|
Closures for containers
|
|
GB1294443A
|
|
Process for the preparation of guanidino derivatives
|
|
IL25194A
|
|
Bisguanidines
|
|
GB1114155A
|
|
Guanidino derivatives
|
|
GB1110947A
|
|
Guanidines
|
|
GB1062898A
|
|
Pharmaceutical compositions containing protamines
|
|
GB1033737A
|
|
Topical medicaments comprising protamine and its derivatives
|
|
DE1184455B
|
|
Process for the preparation of protamine-containing compositions
|
|
GB1033378A
|
|
Stable injectable protamine-active solutions
|
|
GB1033736A
|
|
Stable injectable protamine-active compositions
|
|
US3175942A
|
|
Gastro-intestinal therapeutic
|
|
GB937705A
|
|
Tertiary-amino-substituted amidines and processes for preparing them
|
|
GB905894A
|
|
Improvements in or relating to tablet dispensing devices or appliances
|
|
GB977692A
|
|
Preparation of degraded carrageenin
|
